Jump to content

JCoffman_MW

Members
  • Posts

    2
  • Joined

  • Last visited

Reputation

0 Neutral

About JCoffman_MW

  • Birthday July 7

Profile Information

  • Location
    Arkansas
  1. It does definitely answer the question and helps give me a little better working tools than "I know it's good, just trust me..".
  2. Hope this is the right place. So I am researching using Malwarebytes active protection feature for my firm and I am trying to drill into research that I am not finding easily. Here is what I have: Currently my company is using McAfee as anti-virus protection. McAfee also has its trojan, malware protection embedded into it, but its restrictions are out of control and too tight for our needs so it remains disabled. Obviously there is a gap there that we are trying to fill and I am trying to fill it with MEE and ForeFront Endpoint 2012. We are still piloting Endpoint Protection within our department during investigations to the programs capabilities and inabilities to try and make sure, before we give it to hundreds of users that this will be our best solution. So basically what I have tagged onto this trial period for Forefront Endpoint is testing our Malwarebytes anti-malware solutions through MEE. The questions that I have is what is it going to fill the Windows Defender doesn't? What impact will this have on end-users computer experience? Oviously being a corporation we have a constant need for working within Office suit products along with Adobe, CaseLogistix and a slew of other law specific products. I have to drill down and figure out what works well with these while not inhibiting the users experience at the same time, and given those users hate computers already. Tough world, right? So with that being said, anyone got any good suggestions on reading material or stats?
Back to top
×
×
  • Create New...

Important Information

This site uses cookies - We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.